STOCKWATCH
·
Pharmaceuticals
Open Offer17 Mar 2026, 01:35 pm

Acquirers Make Open Offer for 26% Stake in Rekvina Laboratories at ₹ 10/- Per Share

AI Summary

Rekvina Laboratories Ltd. has received a Public Announcement from Vivro Financial Services Private Limited regarding an Open Offer by Surbhit Mukesh Shah, Amit Mukesh Shah, and Dhruvalkumar Patel to acquire equity shares. The Open Offer is for up to 28,90,100 equity shares, representing 26% of the expanded share capital, at a price of ₹ 10/- per share. The Offer Price is payable in cash, and the Open Offer is not subject to any minimum level of acceptance. The transaction that has triggered the Open Offer obligations is a Share Exchange and Purchase Agreement for the acquisition of 100% of the equity share capital of Radiant Parenterals Limited.

Key Highlights

  • Acquirers making an Open Offer for 26% stake in Rekvina Laboratories Ltd.
  • Offer Price set at ₹ 10/- per share, payable in cash.
  • No minimum level of acceptance required for the Open Offer.
  • Transaction triggering the Open Offer obligations is a Share Exchange and Purchase Agreement for 100% of Radiant Parenterals Limited's equity share capital.
  • Vivro Financial Services Private Limited appointed as Manager to the Open Offer.
VINRKLB
Pharmaceuticals
Rekvina Laboratories Ltd

Price Impact